Tag: Casey Hoyt
Viemed juggles diversified portfolio
May 8, 2026Theresa Flaherty, Managing Editor
LAFAYETTE, La. – Viemed is hitting an inflection point in its ventilator business under new Medicare rules, with stronger compliance and accelerating referrals offset by higher patient turnover. Growth in sleep and maternal health has added to the company’s momentum, says CEO Casey Hoyt.
Ventilator business evolving
A new national coverage determination (NCD) for home mechanical ventilation (HMV), implemented Oct. 22, has several new requirements, including compliance monitoring...
Viemed’s efforts pay off, with revenues increasing 28%
May 6, 2026HME News Staff
LAFAYETTE, La. – Viemed Healthcare reported net revenues of $75.4 million for the first quarter ended March 31, 2026, an increase of $16.3 million, or 28%, over the comparable quarter in 2025.
Net income attributable to Viemed totaled $2.6 million, or $0.06 per diluted share. Adjusted EBITDA was $14.3 million, a 12% increase.
“The first quarter showed clearly that the work we have put into diversifying and scaling this platform is paying off,” said Casey Hoyt, CEO. “Sleep...
Viemed looks to sleep momentum, maternal health acquisition to fuel 2026
March 6, 2026Theresa Flaherty, Managing Editor
LAFAYETTE, La. – Viemed is forecasting “pretty aggressive” growth in its sleep business in the year ahead, driven by strong increases in new patient setups and a corresponding boost in its resupply business, say company execs.
During 2025, new sleep patient setups increased 70% and resupply sales increased 49% year-over-year, said CEO Casey Hoyt on a recent call to discuss the company’s fourth quarter and full year 2025 earnings.
“As the PAP base grows, more patients...
Viemed sees boost from Lehan’s in Q3
November 6, 2025HME News Staff
LAFAYETTE, La. – Viemed Healthcare reported revenue of $71.9 million for the third quarter 2025, a 24% increase compared to the previous quarter in 2024. Adjusted EBITDA totaled $16.1 million, a 15.5% increase.
During the quarter:
Viemed repurchased and cancelled 1,706,380 common shares under its share repurchase program at a cost of $11.4 million, representing an average buyback price of $6.68 per share; and
Closed on its acquisition...
Viemed completes share repurchase
September 29, 2025HME News Staff
LAFAYETTE, La. - Viemed Healthcare has completed all repurchases authorized under its previously announced share repurchase program. "Completing this share repurchase program highlights both our confidence in Viemed's long-term outlook and our ongoing commitment to enhancing shareholder value,” said Casey Hoyt, Viemed's CEO. “With our strong balance sheet and ample liquidity driven by increasing free cash flow, we remain well positioned to continue investing in growth opportunities...
Viemed reports strong sleep therapy growth, eyes resupply boom ahead
August 8, 2025Theresa Flaherty, Managing Editor
LAFAYETTE, La. – Viemed reported strong growth for its second quarter, with the fastest growth in its sleep division, CEO Casey Hoyt said on a recent earnings call.
During the quarter, the company’s sleep therapy patient census was up 15% sequentially and 51% year-over-year. New patient setups were up 72% year-over-year.
“We're focused on aggressively maintaining this growth trend with eight new sleep areas launched since the beginning of the year,”...
Viemed sees ongoing organic growth
August 7, 2025HME News Staff
LAFAYETTE, La. – Viemed Healthcare remained “on track” during the second quarter of 2025, reporting revenue of $63.1 million, an increase of 14.7% over the same period in 2024.
Adjusted EBITDA for the quarter totaled $14.3 million, an 11.5% increase.
"The solid execution of our vent and sleep businesses - together with continued leveraging of expenses - produced second quarter results that met our expectations and kept us on track for our organic growth...
Viemed authorizes share repurchase program
June 10, 2025HME News Staff
LAFAYETTE, La. – Viemed Healthcare’s board of directors has authorized a share repurchase program, effective through June 2026. Under the share repurchase program, Viemed may purchase up to 1,976,441 common shares of the company from time to time in accordance with applicable securities laws, representing approximately 5% of the total issued and outstanding common shares as of March 31, 2025. “Our recent first quarter 2025 results and the increases in our 2025 guidance range midpoints...
Viemed posts record-breaking 2024
March 11, 2025HME News Staff
LAFAYETTE, La. – Viemed Healthcare reported record net revenues of $60.7 million for its fourth quarter 2024, an increase of 20% over the same quarter in 2023.
Total net revenues for the year were a record $224.3 million, an increase of $41.2 million, or 23% over the prior year. Adjusted EBITDA for the quarter and the year were $14.2 million and a record $51.1 million, respectively.
“We once again demonstrated our value as a vital link between patients, providers,...
Viemed ‘earns trust,’ sees growth
November 7, 2024HME News Staff
LAFAYETTE, La. – Viemed Healthcare reported revenues of $58 million for the third quarter of 2024, an increase of 17.4% year over year and an increase of 5.5% sequentially.
The company increased its ventilator patient count by 11% sequentially to 11,374 and increased its sleep therapy patient count by 11% sequentially to 19,478.
“Viemed continues to earn a trusted place in the home with our high-touch, technology-enabled clinical approach to delivering complex respiratory...